Keenova Therapeutics Plc's ROI from its first quarter of 2026 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Keenova Therapeutics Plc's ROI in the first quarter of 2026?
Keenova Therapeutics Plc recorded a cumulative net loss of $-573 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -11.44%.

Within the Healthcare sector 285 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 2839 to 3109.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 26 2025) III. Quarter	(Mar 28 2025) I. Quarter	(Sep 27 2024) III. Quarter
Y / Y Investment Change TTM	59.54 %	35.74 %	34.26 %	-13.95 %	-22.43 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	4,837	4,957	7,397	2,852	3,084
Return On Investment (TTM)	-11.44 %	-10.63 %	-9.46 %	-5.34 %	59.53 %
MNK's Overall Ranking	# 3109	# 2839	# 2932	# 2747	#
Seq. Investment Change TTM	9.58 %	11.35 %	34.83 %	-3.03 %	-6.77 %
Seq. Net Income Change TTM	-	-	-	-	993.33 %
Net Income (TTM) in Millions	-573	-486	-388	-163	1,870

MNK Company Profile >> Back to MNK Roi Comparisons >> See Annual MNK Return On Investment

Return On Investment MNK's Ranking
Within:	No.
Industry	# 98
Sector	# 286
Overall	# 3109

Return On Investment Statistics
High	Average	Low
59.53 %	-11.3 %	-70.18 %
(Sep 27 2024)		(Sep 29 2023)

Financial Statements
Keenova Therapeutics Plc's I. Quarter Investments	$ 4,837 Millions	MNK's Balance sheet
Keenova Therapeutics Plc's I. Quarter Income	$ -114 Millions	Quarterly MNK's Income Statement
MNK's Income by Division		See MNK's Income by Division

MNK Annual Return On Investment	(Dec 31 2025) 2025	(Dec 29 2023) 2023	(Dec 30 2022) 2022
Total Investments in Millions	4,729	3,232	5,270	0	0
Y / Y Investment Growth	46.29 %	-38.66 %	-	-	-
Net Income in Millions	-490	-717	-717	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-10.35 %	-22.19 %	-13.61 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MNK's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MNK's Competitors
Subscribers only: Roi for Keenova Therapeutics Plc's Suppliers
Subscribers only: Return On Investment for MNK's Customers

Other Ratios
MNK's Roa	MNK's Inventory Turnover Ratio	MNK's Growth Rates	MNK's Dividend Statistics
	MNK's Profitability Ratios	MNK's Asset Turnover Ratio	MNK's Dividend Growth
MNK's Roe	MNK's Valuation Ratios	MNK's Financial Strength Ratios	MNK's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T06:54:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.